1. Belenkov YuN., Mareev VYu., Ageev FT., Fomin IV., Badin YuV., Polyakov DS. et al. Veritable prevalence of CHF in the European part of Russia (EPOCHA trial, Hospital stage). Journal Serdechnaya Nedostatochnost’. 2011;12(2):63-68. (in Russ).
2. Maisel WH, Stevenson LW. Atrial fi brillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2D–8D. doi:10.1016/S0002- 9149(02)03373-8
3. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. European Heart Rhythm Association. European Association for Cardio-Th oracic Surgery Guidelines for the management of atrial fi brillation: Th e Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2011; 31(19):2369–2429. doi: 10.12968/bjca.2011.6.5.240
4. Mareyev VYu., Fomin IV., Ageyev FT., Arutyunov GP., Begrambekova YuL., Belenkov YuN. at al. Clinical recommendations. Chronic heart failure (CHF). Journal Serdechnaya Nedostatochnost’. 2017;18(1):3–40. (in Russ). doi: 10.18087/rhfj .2017.1.2346
5. Belenkov YuN., Mareev YuV. How do we diagnose and treat heart failure in clinical practice at the beginning of the XXI century? Th e results of the study IMPROVEMENT HF. Consilium medicum. 2001;3(2):35-39. (in Russ).